Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP815107.RAplHKV8lbHw9xgOztnoxw1hfvJ1Kb-vOjrs0rZak70rI130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815107.RAplHKV8lbHw9xgOztnoxw1hfvJ1Kb-vOjrs0rZak70rI130_provenance.
• NP815633.RA5KwoMoHSebSQ7_s5Zb4rAJCqoDmRo0AT4buuB5iXhRM130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP815633.RA5KwoMoHSebSQ7_s5Zb4rAJCqoDmRo0AT4buuB5iXhRM130_provenance.
• NP919901.RAyffYSgzewLqTG3Dcq45bnvxvUdiZLupiyLF5IgdM0Ak130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919901.RAyffYSgzewLqTG3Dcq45bnvxvUdiZLupiyLF5IgdM0Ak130_provenance.
• NP554557.RAVkIJgD0O0B6RW4cG8hhD9zNgv3Wv6NMiLS5csuDD4_c130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP554557.RAVkIJgD0O0B6RW4cG8hhD9zNgv3Wv6NMiLS5csuDD4_c130_provenance.
• NP946189.RAQNRKoNtVVpvUex3peyZ-7PypAG0-uCBFKknfAYU3yZk130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP946189.RAQNRKoNtVVpvUex3peyZ-7PypAG0-uCBFKknfAYU3yZk130_provenance.
• assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP572502.RAcO2Rk8hAUHn7s2kqKVgTRGJ70bLVg5Db3IStTaWESaQ130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572502.RAcO2Rk8hAUHn7s2kqKVgTRGJ70bLVg5Db3IStTaWESaQ130_provenance.
• NP803247.RA3JcIJOJVU7Tn5TOevP8bASKuecEacN8tawQkt99yvU8130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP803247.RA3JcIJOJVU7Tn5TOevP8bASKuecEacN8tawQkt99yvU8130_provenance.
• NP572498.RA294iJ4GxQieOqOXf9b7gKM6vTunkmy0KM_sFl7YTMxU130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572498.RA294iJ4GxQieOqOXf9b7gKM6vTunkmy0KM_sFl7YTMxU130_provenance.
• NP572505.RA-yBzH9OWEimeLI2atuweW5qo9S1VNz1XqZHCc2jvEKg130_assertion description "[Subsequently, the disseminated mesenchymal tumour cells must undergo a reverse transition (mesenchymal-epithelial transition, MET) at the site of metastases, as most metastases recapitulate the pathology of their corresponding primary tumours.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP572505.RA-yBzH9OWEimeLI2atuweW5qo9S1VNz1XqZHCc2jvEKg130_provenance.